| Jagsonpal Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 507789 |
NSE Symbol : JAGSNPHARM |
P/E(TTM) : 47.43 |
|
ISIN Demat : INE048B01027 |
Div & Yield% : 1.22 |
EPS(TTM) : 8.61 |
|
Book Value(₹) : 70.84 |
Market Cap(₹Cr) : 1,080.38 |
Face Value(₹) : 5.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 61.44 | 43.49 | 47.23 | 57.83 | 60.15 | 55.45 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 61.44 | 43.49 | 47.23 | 57.83 | 60.15 | 55.45 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.44 | 2.49 | 2.52 | 2.27 | 2.00 | 2.56 |
| Total Income | 62.88 | 45.97 | 49.76 | 60.10 | 62.15 | 58.01 |
| Total Expenditure | 54.49 | 40.82 | 43.84 | 49.46 | 51.52 | 50.01 |
| PBIDT | 8.40 | 5.16 | 5.92 | 10.64 | 10.63 | 8.00 |
| Interest | 0.22 | 0.22 | 0.23 | 0.22 | 0.15 | 0.20 |
| PBDT | 8.18 | 4.94 | 5.69 | 10.42 | 10.48 | 7.80 |
| Depreciation | 1.07 | 0.40 | 0.41 | 0.46 | 0.39 | 0.48 |
| Tax | 1.59 | 1.00 | 1.37 | 2.58 | 2.60 | 1.54 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.19 | -0.02 | -0.06 | -0.09 | 0.01 | 0.18 |
| Reported Profit After Tax | 5.33 | 3.55 | 3.96 | 7.47 | 7.48 | 5.60 |
| Extra-ordinary Items | -2.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 7.79 | 3.55 | 3.96 | 7.47 | 7.48 | 5.60 |
| EPS (Unit Curr.) | 1.94 | 1.31 | 1.48 | 2.84 | 2.85 | 2.14 |
| EPS (Adj) (Unit Curr.) | 1.94 | 1.31 | 1.48 | 2.84 | 2.85 | 2.14 |
| Calculated EPS (Unit Curr.) | 2.01 | 1.34 | 1.51 | 2.85 | 2.85 | 2.14 |
| Calculated EPS (Adj) (Unit Curr.) | 2.01 | 1.34 | 1.51 | 2.85 | 2.85 | 2.14 |
| Calculated EPS (Ann.) (Unit Curr.) | 8.06 | 5.37 | 6.03 | 11.41 | 11.42 | 8.55 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 8.06 | 5.37 | 6.03 | 11.41 | 11.42 | 8.55 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.23 | 13.22 | 13.14 | 13.10 | 13.10 | 13.10 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 13.67 | 11.86 | 12.53 | 18.40 | 17.67 | 14.43 |
| PBDTM(%) | 13.31 | 11.36 | 12.05 | 18.02 | 17.42 | 14.07 |
| PATM(%) | 8.68 | 8.16 | 8.38 | 12.92 | 12.44 | 10.10 |